중재 X선 시장에서 글로벌 요오드화 대조 매체 – 2031년까지의 산업 동향 및 예측

중재 X-선 시장 분석 및 규모에 대한 요오드화 대조 매체

중재적 X선 시장에서 요오드 조영제, 특히 요오드 조영제는 매년 심혈관 질환으로 인한 전 세계 사망자가 390만 명에 달하는 상당한 성장이 예상되며, 다양한 회사가 보유한 특허 만료로 제네릭 생산업체가 기술 비용을 절감할 수 있는 길이 열릴 것입니다. 이러한 변화는 기술의 이점에 대한 접근성을 확대하여 긴급한 의료 문제를 해결할 것으로 예상됩니다.

Data Bridge Market Research는 2023년에 26억 4천만 달러였던 중재용 X선 검사의 글로벌 요오드 조영제 시장을 분석하고, 2031년까지 41억 5천만 달러에 도달할 것으로 예상하며, 2024년부터 2031년까지의 예측 기간 동안 연평균 성장률은 5.80%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화      

Market Definition

Iodinated contrast media in interventional X-ray refers to a type of contrast agent containing iodine that enhances visibility of blood vessels and soft tissues during medical imaging procedures. Widely used in interventional radiology, it helps improve the clarity of X-ray images, aiding in the diagnosis and treatment of cardiovascular conditions. The market for this technology is expected to grow significantly, driven by increasing demand and accessibility.

Global Iodinated Contrast Media in Interventional X-Ray Market Dynamics

Drivers

• Rising Cardiovascular Disease Cases Increasing Demand for Advanced Diagnostic Tools

The escalating prevalence of cardiovascular diseases (CVD) globally, causing 3.9 million deaths annually, is a primary driver for the iodinated contrast media in interventional X-Ray market. As the incidence of cardiac conditions continues to surge, there is an increasing demand for advanced diagnostic tools, such as interventional X-Ray with iodinated contrast media, to facilitate accurate and timely diagnosis, leading to a substantial market growth.

• Patent Expirations and Generic Competition

The upcoming expiration of patents held by various companies is a significant driver shaping the iodinated contrast media market. As these patents expire, it opens avenues for generic pharmaceutical producers to enter the market. This influx of generic alternatives is expected to intensify competition, reducing the overall cost of the technology. Lower prices are such asly to enhance accessibility, enabling a broader population to avail the advantages of interventional X-Ray procedures, further driving the market expansion.

Opportunities

• Technological Advancements and Diversification Reducing the Risk of Adverse Reactions

Ongoing technological advancements in iodinated contrast media offer opportunities for enhanced formulations with improved safety profiles and diagnostic capabilities. Continuous research and development can lead to innovations such as low-osmolar contrast agents, reducing the risk of adverse reactions. Additionally, diversifying the applications of contrast media beyond cardiovascular interventions to other medical fields, such as oncology or neurology, can open up new markets and revenue streams, further contributing to the growth of the interventional X-Ray market.

• Emerging Markets and Global Healthcare Accessibility

The expanding healthcare infrastructure in emerging markets, coupled with a growing awareness of diagnostic procedures, presents a considerable opportunity for iodinated contrast media. As healthcare systems in developing regions improve, the demand for advanced imaging technologies is such asly to rise. Moreover, initiatives to enhance global healthcare accessibility may lead to increased adoption of interventional X-Ray procedures using iodinated contrast media, creating a broader market and contributing to the technology's global expansion.

Restraints/Challenges

• Renal Toxicity Concerns Restricting the Usage of Iodinated Contrast Media

Iodinated contrast media can pose a risk of renal toxicity, particularly in patients with pre-existing kidney conditions. The use of these agents may lead to contrast-induced nephropathy, limiting their application in individuals with compromised renal function. This concern has prompted careful consideration and monitoring, restricting the usage of iodinated contrast media in certain patient populations.

• Allergic Reactions and Adverse Effects

The potential for allergic reactions and adverse effects associated with iodinated contrast media. Some patients may experience mild to severe allergic responses, ranging from skin rashes to life-threatening anaphylaxis. This restricts the use of these agents in individuals with a history of iodine-related allergies.

This global iodinated contrast media in interventional X-Ray market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global iodinated contrast media in interventional X-Ray market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2021, GE Healthcare bolstered its ultrasound portfolio and advanced into surgical imaging by acquiring BK Medical. This strategic move not only expanded GE's capabilities but also contributed to the development of precision health through the integration of BK Medical's expertise
• In 2021, Koninklijke Philips N.V. collaborated with DiA Imaging Analysis Ltd. to enhance operational efficiency and care accessibility for point-of-care (POC) clients both within and outside hospitals. Philips leveraged DiA's automated solutions, integrated with ultrasound devices, aiming to improve diagnostic capabilities
• In 2019, General Electric strengthened its position in the Japanese market by transferring marketing rights for four diagnostic imaging agents through an agreement with Daiichi Sankyo Company. This move, completed in 2019, facilitated GE Healthcare's expansion and enhancement of diagnostic imaging agents in Japan, contributing to increased business presence

Global Iodinated Contrast Media in Interventional X-Ray Market Scope

The global iodinated contrast media in interventional X-Ray market is segmented on the basis of route of administration, indication, agent type, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Route of Administration

• Intravenous
• Oral
• Rectal
• Others

Indication

• Cardiology
• Neurology
• General Surgery
• Oncology
• Urology

Agent Type

• Non-Ionic
• Ionic

End-User

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Other

Global Iodinated Contrast Media in Interventional X-Ray Market Regional Analysis/Insights

The global iodinated contrast media in interventional X-Ray market is analyzed and market size insights and trends are provided by route of administration, indication, agent type, end-user and distribution channel as referenced above.

The major countries covered in the global iodinated contrast media in interventional X-Ray market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the iodinated contrast media market, driven by widespread adoption in CT procedures and the availability of non-ionic stable iodinated agents, enhancing diagnostic precision. Government initiatives promoting cancer and cardiac awareness, coupled with the introduction of innovative contrast agent products by various companies, contribute to the region's projected growth at an accelerated rate.

아시아 태평양 지역은 고급 영상 기술의 광범위한 채택과 비이온성 안정 요오드화 제제의 접근성 증가로 인해 중재적 X선 검사 시장 점유율이 크게 증가하고 있으며, 진단 기능이 향상되고 있습니다. 또한 중국과 인도에서 의료비 지출이 증가하고 병원과 영상 센터가 급증하면서 중재적 X선 검사에서 요오드화 조영제에 대한 수요가 크게 증가하고 있습니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

의료 인프라 성장 설치 기반 및 신기술 침투

글로벌 요오드화 조영제 중재 X선 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 글로벌 요오드화 조영제 중재 X선 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용하는 기술의 영향, 의료 규제 시나리오의 변화 및 글로벌 요오드화 조영제 중재 X선 시장에 미치는 영향. 이 데이터는 2016-2021년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 글로벌 요오드화 조영제 중재 X선 시장 점유율 분석

개입형 X선 시장에서 글로벌 요오드화 조영제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 개입형 X선 시장에서 글로벌 요오드화 조영제와 관련된 회사의 초점에만 관련이 있습니다.

글로벌 중재 X선 시장에서 활동하는 요오드 조영제 주요 기업은 다음과 같습니다.

• Bayer AG(독일)
• Iso-Tex Diagnostics, Inc. (미국)
• Bracco Diagnostic Inc.(이탈리아)
• Novalek Pharmaceuticals Pvt. Ltd.(인도)
• 태준제약(한국)
• Unijules Life Sciences Ltd(인도)
• 제너럴 일렉트릭(미국)
• 게르베(프랑스)
• JBPharma(인도)

SKU-50696